Suzanne Doubrava

M.D. | Psychiatry | 21+ years Exp


  333 Cottman Ave, Philadelphia
     Pennsylvania, 19111
  215-214-3940    215-214-1425 Maps & Directions
Suzanne Doubrava is a Philadelphia, Pennsylvania based psychiatrist with 21 years of experience in Psychiatry. She completed her graduation in 2003. and . She accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Suzanne Doubrava is MD466312 for Psychiatry in Pennsylvania. Her current practice location is 333 Cottman Ave, Philadelphia. Patients can reach her at 215-214-3940 or can fax her at 215-214-1425. Suzanne Doubrava is M.D. in Psychiatry and her NPI number (Unique professional ID assigned by NPPES) is 1104076058.
Suzanne Doubrava specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.
Complete Profile:
Suzanne Doubrava speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Suzanne Doubrava
Specialization: Psychiatry
Gender:Female
Credentials: M.D.
Experience: 21+ years
Medical School Attended:Other
Graduation Year:2003
Accepts Medicare Assignment:Yes
Practice Address:333 Cottman Ave, Philadelphia,
Pennsylvania, 19111
Phone:215-214-3940
Fax:215-214-1425
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 1254481096
Enrollment ID: I20190304002375
NPI Number: 1104076058
NPI Enumeration Date: 29 Sep, 2008
NPI Last Update On: 12 Feb, 2019

Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Suzanne Doubrava are as mentioned below.
License NumberSpecializationStateStatus
MD466312Psychiatry PennsylvaniaPrimary
25MA08185400Psychiatry New JerseySecondary
Hospital Affiliation:
Surgeons are affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
Hospital Name (CCN) State Hospital Type
(390027)Philadelphia, PAAcute Care Hospital
(390196)
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name with which Suzanne Doubrava is associated with along with the number of members in that group.
Organization Name (Group PAC ID) Members
Temple Faculty Practice Plan Inc (0345588711)1021
Other Medical Identifiers:
Other legacy medical identifiers associated with Suzanne Doubrava such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
IdentifierTypeStateIssuer
P00919249OtherNew JerseyRR MCR PTAN
0211427MedicaidNew Jersey
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Suzanne Doubrava
2450 W Hunting Park Ave # Cab2200,
Philadelphia, Pennsylvania
Zip: 19129-1302
Phone Number: 215-214-3940
Fax Number: 215-214-1425
Patients can reach Suzanne Doubrava at 333 Cottman Ave, Philadelphia, Pennsylvania or can call to book an appointment on 215-214-3940.
Comments/ Reviews:

*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.